Semaglutide and pancreatitis
Table of Contents 1. Introduction In recent years, the pharmaceutical landscape for managing type 2 diabetes and obesity has been significantly reshaped by the introduction of semaglutide, a medication that offers a new horizon for patients struggling with these chronic conditions. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered attention not only for its …